Board of Directors
Ms. Schiaparelli is passionate about bringing cutting-edge medical technologies to markets to help improve the lives of patients. With more than 20 years of experience in the healthcare industry, she has honed her expertise in leading innovative healthcare organizations, driving them to success with business strategy for healthcare technologies and care providers, specializing in global medical device commercialization, emerging technologies, strategic marketing, healthcare consumerism, and patient care pathway modeling.
Jill has held leadership roles with major healthcare companies such as Johnson & Johnson and Baxter as well as serving as an executive at high-growth, innovative companies such as ApaTech (UK), a company she helped sell to Baxter, AxoGen where she assisted their up-list to NASDAQ, InteloMed where she launched the CVInsight™ Monitoring and Informatics System, and Neurotechnology Innovations Translator, an incubator and investment vehicle to launch and grow companies in the neuromodulation space.
Jill has a MBA in Finance and Business Management from the Stern School of Business at New York University and a BS in Finance and International Management from the Questrom School of Business at Boston University.